Pauli Ylikotila

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design

Jukka Putaala, Nicolas Martinez‐Majander, Sahrai Saeed et al. · European Stroke Journal · 2017 · 55 citations · Full text

Medicine, Cardiology, Neurology +17

Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial

Nicolas Martinez‐Majander, George Ntaios, Y. Y. Liu et al. · European Journal of Neurology · 2020 · 54 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

Association between Migraine and Cryptogenic Ischemic Stroke in Young Adults

Nicolas Martinez‐Majander, Ville Artto, Pauli Ylikotila et al. · Annals of Neurology · 2020 · 53 citations · Full text

Life Sciences, Neurology, Clinical Neuroscience +16

Genetics of early-onset Parkinson's disease in Finland: exome sequencing and genome-wide association study

Ari Siitonen, Michael A. Nalls, Dena G. Hernandez et al. · Neurobiology of Aging · 2017 · 51 citations

Life Sciences, Genetics, Molecular Genetics +16